Amundi Asset Management US’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$75.1M Buy
266,377
+26,715
+11% +$7.53M 0.06% 328
2020
Q4
$67.9M Buy
239,662
+463
+0.2% +$131K 0.06% 324
2020
Q3
$65.8M Buy
239,199
+28,408
+13% +$7.81M 0.07% 279
2020
Q2
$47.9M Buy
210,791
+54,596
+35% +$12.4M 0.06% 316
2020
Q1
$23.8M Buy
156,195
+14,771
+10% +$2.25M 0.04% 368
2019
Q4
$21.3M Sell
141,424
-10,618
-7% -$1.6M 0.02% 540
2019
Q3
$21.6M Buy
152,042
+4,706
+3% +$667K 0.03% 488
2019
Q2
$41.1M Buy
147,336
+115,162
+358% +$32.1M 0.03% 374
2019
Q1
$3.55M Sell
32,174
-24,944
-44% -$2.75M 0.01% 963
2018
Q4
$5.6K Sell
57,118
-4,936
-8% -$484 0.01% 807
2018
Q3
$7.66M Buy
62,054
+53,365
+614% +$6.59M 0.01% 800
2018
Q2
$863K Sell
8,689
-33,575
-79% -$3.33M ﹤0.01% 1276
2018
Q1
$3.73M Buy
42,264
+1,125
+3% +$99.3K 0.01% 926
2017
Q4
$4.06M Buy
+41,139
New +$4.06M 0.01% 895